TERN vs WELL · $6.12B cap vs P/E 100, rev $10.84B
Terns Pharmaceuticals Inc (TERN) versus Welltower Inc (WELL) — a side-by-side from cached financials, not a winner call.
Terns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.
Welltower Inc (WELL) is a reit - healthcare facilities company listed on NYSE.
Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. TERN currently screens at market cap $6.12B.
Latest reported WELL revenue for 2025-12-31 was $10.84B. Net income was $936.8M. Revenue was up 35.6% from 2024-12-31 to 2025-12-31. WELL currently screens at market cap $145.81B and trailing P/E 99.8.
TERN currently screens at market cap $6.12B. WELL currently screens at market cap $145.81B and trailing P/E 99.8.
Not investment advice. Open the TERN and WELL stock pages for the full models.
Not investment advice.